HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamine

has antineoplastic activity; structure in first source
Also Known As:
6-chloro-4MDMPA; BIIB021; CNF 2024; CNF-2024; CNF2024
Networked: 26 relevant articles (2 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Lundgren, Karen: 4 articles (03/2010 - 04/2009)
2. Zhang, Hong: 3 articles (03/2010 - 04/2009)
3. Lin, Shengyun: 2 articles (05/2021 - 06/2014)
4. Wang, Bo: 2 articles (05/2021 - 06/2014)
5. Choi, Moon Gi: 2 articles (11/2020 - 10/2016)
6. Ihm, Sung-Hee: 2 articles (11/2020 - 10/2016)
7. Kang, Jun Goo: 2 articles (11/2020 - 10/2016)
8. Kim, Si Hyoung: 2 articles (11/2020 - 10/2016)
9. Lee, Seong Jin: 2 articles (11/2020 - 10/2016)
10. He, Wei: 2 articles (07/2018 - 04/2016)

Related Diseases

1. Lymphoma (Lymphomas)
2. Breast Neoplasms (Breast Cancer)
3. Hematologic Neoplasms (Hematological Malignancy)
4. Leukemia
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. 6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamine
2. 5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide
3. NVP-BEP800
4. STA 9090
5. Proteins (Proteins, Gene)
6. tanespimycin (17AAG)
7. purine
8. triptolide
9. Histone Acetyltransferases (Histone Acetyltransferase)
10. Therapeutic Uses

Related Therapies and Procedures

1. Radiotherapy
2. Oral Administration